8-K: OneMedNet Regains Nasdaq Listing Compliance

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a previous listing issue.

Summary

• OneMedNet Corporation received a notice on October 8, 2025, confirming it has regained compliance with Nasdaq Listing Rule 5550(a)(2).
• The company was previously notified on April 10, 2025, of non-compliance with the $1.00 minimum bid price requirement, with a grace period until October 7, 2025.
• The closing bid price of the company's common stock was at least $1.00 per share for 10 consecutive business days from September 24, 2025, through October 7, 2025.
• This matter is now closed, and the company remains listed on The Nasdaq Capital Market.

Sentiment

Score: 8

Explanation: The resolution of a significant listing compliance issue is a strong positive, removing a major overhang and uncertainty for the company and its investors. This indicates stability in its public market presence.

Positives

• Regained compliance with Nasdaq's $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)).
• The delisting matter is now closed, removing a significant uncertainty for investors.
• Common stock maintained a closing bid price of at least $1.00 for 10 consecutive business days from September 24, 2025, to October 7, 2025.

Negatives

• Previously received a notice of non-compliance with Nasdaq's minimum bid price requirement on April 10, 2025.

Risks

• The company was at risk of delisting from The Nasdaq Capital Market due to non-compliance with the $1.00 minimum bid price rule, a risk that has now been mitigated.

Future Outlook

The filing indicates that the company has successfully resolved its Nasdaq listing compliance issue, removing a significant uncertainty regarding its continued listing on The Nasdaq Capital Market.

Management Comments

• Aaron Green, Chief Executive Officer, signed the report on behalf of OneMedNet Corporation.

Industry Context

Maintaining listing on a major exchange like Nasdaq is crucial for public companies to ensure liquidity, investor confidence, and access to capital markets. Compliance with listing rules is a fundamental requirement for all publicly traded entities, and failure to comply can lead to delisting, impacting a company's ability to raise funds and its public perception.

Stakeholder Impact

• Shareholders: Reduced risk of delisting, potentially stabilizing stock price and improving investor confidence.
• Company Management: Successful resolution of a regulatory challenge, allowing focus on core business operations.

Key Dates

Recommendation

The company has successfully resolved a significant delisting risk, which is a positive development. This removes a major uncertainty and potential downward pressure on the stock. While this is a positive, the filing does not provide new information on operational performance or strategic growth, thus a 'hold' recommendation is appropriate for existing investors as the immediate risk has been mitigated, but no new catalysts for significant upside are presented. For new investors, it removes a barrier, making it a more stable consideration.

Keywords

OneMedNet, ONMD, Nasdaq, Listing Compliance, Minimum Bid Price, SEC Filing, 8-K, Stock Market, Delisting Risk